{
    "clinical_study": {
        "@rank": "129344", 
        "acronym": "EMPIRICUS", 
        "arm_group": [
            {
                "arm_group_label": "Micafungin", 
                "arm_group_type": "Active Comparator", 
                "description": "MYCAMINE 100 mg intravenous an injection of 24 hours"
            }, 
            {
                "arm_group_label": "PLACEBO", 
                "arm_group_type": "Placebo Comparator", 
                "description": "0.9% sodium chlorides 100ml infusion"
            }
        ], 
        "brief_summary": {
            "textblock": "Invasive Candida infections are burdened with a high mortality rate and is very common in\n      intensive care units. This study aims to evaluate the efficacy of empirical treatment with\n      micafungin in adult patients with suspected invasive candidiasis."
        }, 
        "brief_title": "Empirical Antifungal Treatment in ICUS", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Invasive Candidiasis", 
        "condition_browse": {
            "mesh_term": [
                "Candidiasis", 
                "Candidiasis, Invasive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Multicenter, randomized, double-blind parallel groups comparing adult patients with\n      suspected invasive candidiasis input from a 14-day empirical treatment with micafungin\n      (MYCAMINE 100 mg) with placebo on survival without invasive candidiasis in 28 days after\n      initiation of study treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years\n\n          -  Persistent sepsis without documented invasive candidiasis:\n\n        systemic inflammatory response syndrome (SIRS) presence of two signs on the 4 [temperature\n        <36 \u00b0 C or> 38 \u00b0 C, heart rate> 90/min, respiratory rate> 20/min or PaCO2 <32 mmHg,\n        leukocytosis> 12,000 / mm3, <4.000/mm3 or presence of circulating immature forms (> 10% of\n        cells)] mechanical ventilation (intubation or tracheostomy) for over 4 days (96 hours)\n        central line use of broad-spectrum antibacterial for more than 4 calendar days (96 hours)\n        in the previous week presence of at least one extra-digestive site colonized by Candida\n        sp. (Urine, mouth, throat, upper and lower respiratory tract, skin folds, and suction\n        drains after surgery ...), not lower digestive tract, are not taken into account the\n        positive samples of rectal swabs and / or stool cultures, absence of proven bacterial\n        infections untreated no evidence of invasive fungal infections (positive blood culture,\n        positive culture of a surgical site, deep biopsy with fungal) infection or mold according\n        to the criteria of the group \"fungal infection of the EORTC\" organ failure\n\n          -  Hospitalization in intensive care for over 5 days (120 hours)\n\n          -  Giving a free, informed and in writing. In the absence of the person of trust or a\n             family member (if present)consent to emergency possible.\n\n          -  Receiving a social security system,\n\n          -  Negative pregnancy test for patients of childbearing age\n\n        Exclusion Criteria:\n\n          -  Proven invasive fungal infection (positive blood culture, positive culture of a\n             surgical site, deep biopsy with fungal infection), including aspergillosis requiring\n             antifungal therapy at the time of randomization\n\n          -  Prognosis of less than 48 hours (for which the patient outcome will be fatal whatever\n             treatment),\n\n          -  Echinocandin antifungal treatment by more than one day or another antifungal for over\n             72 hours in the week before the inclusion visit,\n\n          -  Allergy, hypersensitivity or known intolerance to echinocandins antifungal or any of\n             the excipients of the drug\n\n          -  Neutropenia (ANC <500/mm3)\n\n          -  History of organ and bone marrow,\n\n          -  Recent chemotherapy (less than 6 months)\n\n          -  Systemic immunosuppressive therapy in progress, other than with corticosteroids at\n             doses below 2 mg / kg / day of prednisolone or equivalent\n\n          -  Participation in another interventional study in the same ICU stay or making\n             treatment being evaluated within 28 days prior to randomization\n\n          -  Any clinical investigator deems incompatible with the conduct of the study in\n             acceptable security conditions\n\n          -  Pregnant and lactating women,\n\n          -  Adults subject to a legal protection measure\n\n          -  Persons deprived of their liberty by a judicial or administrative decision, those\n             hospitalized without consent, persons admitted to a health facility or social\n             purposes other than research"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "260", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01773876", 
            "org_study_id": "1126", 
            "secondary_id": "2011-005451-14"
        }, 
        "intervention": [
            {
                "arm_group_label": "Micafungin", 
                "description": "MYCAMINE 100 mg intravenous 100 mg of powder reconstituted in a 100 ml infusion bag of sodium chloride 0.9%\ninfusion over 24 hours for 14 days discontinuation of treatment if proven invasive candidiasis", 
                "intervention_name": "Micafungin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "PLACEBO", 
                "description": "solution of sodium chloride 0.9% 100 ml for intravenous infusion infusion over 24 hours for 14 days discontinuation of placebo if proven invasive candidiasis", 
                "intervention_name": "PLACEBO", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Micafungin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "survival without proven invasive candidiasis", 
            "effectiveness", 
            "micafungin versus placebo", 
            "pharmacokinetic", 
            "pharmacodynamic", 
            "tolerance"
        ], 
        "lastchanged_date": "January 29, 2013", 
        "location": [
            {
                "contact": {
                    "email": "obaldesi@ch-aix.fr", 
                    "last_name": "Olivier OB BALDESI, Dr", 
                    "phone": "0033442335024"
                }, 
                "facility": {
                    "address": {
                        "city": "Aix en Provence", 
                        "country": "France", 
                        "zip": "13616"
                    }, 
                    "name": "Hospital Aix en Provence"
                }, 
                "investigator": {
                    "last_name": "Olivier OB BALDESI, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jcnavellou@chu-besancon.fr", 
                    "last_name": "Jean Christophe JCN NAVELLOU, Dr", 
                    "phone": "0033381668127"
                }, 
                "facility": {
                    "address": {
                        "city": "Besan\u00e7on", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "Hospital University of Besan\u00e7on"
                }, 
                "investigator": {
                    "last_name": "Jean Christophe JCN NAVELLOU, DR", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "yves.cohen@avc.aphp.fr", 
                    "last_name": "Yves YC COHEN, dr", 
                    "phone": "0033148955249"
                }, 
                "facility": {
                    "address": {
                        "city": "Bobigny", 
                        "country": "France", 
                        "zip": "93009"
                    }, 
                    "name": "University Hospital of Avicennes"
                }, 
                "investigator": {
                    "last_name": "Yves YC COHEN, DR", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "didier.gruson@chu-bordeaux.fr", 
                    "last_name": "Didier DG GRUSON, Dr", 
                    "phone": "0033556795517"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33000"
                    }, 
                    "name": "Hospital University of Bordeaux"
                }, 
                "investigator": {
                    "last_name": "Didier DG GRUSON, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "bsouweine@chu-clermontferrand.fr", 
                    "last_name": "Bertrand BS SOUWEINE, PU-PH", 
                    "phone": "0033473754983"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "Hospital University of Clermont Ferrand"
                }, 
                "investigator": {
                    "last_name": "Bertrand BS SOUWEINE, Pu-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "catherine.paugam@bjn.aphp.fr", 
                    "last_name": "Catherine CPB PAUGAM-BURTZ, Dr", 
                    "phone": "0033140875911"
                }, 
                "facility": {
                    "address": {
                        "city": "Clichy", 
                        "country": "France", 
                        "zip": "92110"
                    }, 
                    "name": "University Hospital of Beaujon"
                }, 
                "investigator": {
                    "last_name": "Catherine CPB PAUGAM-BURTZ, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "pierre-emmanuel.charles@chu-dijon.fr", 
                    "last_name": "Pierre Emmanuel PEC CHARLES, Dr", 
                    "phone": "0033380293751"
                }, 
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "University Hospital of Dijon"
                }, 
                "investigator": {
                    "last_name": "Pierre Emmanuel PEC CHARLES, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "nicolasbele@free.fr", 
                    "last_name": "Nicolas NB BELE, Dr", 
                    "phone": "0033494605071"
                }, 
                "facility": {
                    "address": {
                        "city": "Draguignan", 
                        "country": "France", 
                        "zip": "83300"
                    }, 
                    "name": "Hospital of Draguignan"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicolas NB BELE, Dr", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Riyad RF FARHAT, Dr", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "JFTimsit@chu-grenoble.fr", 
                    "last_name": "Jean Francois JFT TIMSIT, PU-PH", 
                    "phone": "0033476768779"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "Hospital University of Grenoble"
                }, 
                "investigator": [
                    {
                        "last_name": "Jean Francois JFT TIMSIT, Pu-PH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Rebecca RH HAMDIFAR-ROY, Dr", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "FBRUNEEL@ch-versailles.fr", 
                    "last_name": "BRUNEEL BF Fabrice, Dr", 
                    "phone": "0033139638842"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Chesnay", 
                        "country": "France", 
                        "zip": "78150"
                    }, 
                    "name": "Hospital of Versailles"
                }, 
                "investigator": {
                    "last_name": "BRUNEEL BF Fabrice, dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "laurent.argaud@chu-lyon.fr", 
                    "last_name": "ARGAUD AL Laurent, Dr", 
                    "phone": "0033472110015"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "96433"
                    }, 
                    "name": "University Hospital Edouard Herriot"
                }, 
                "investigator": {
                    "last_name": "Argaud AL Laurent, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bernard.allaouchiche@gmail.com", 
                    "last_name": "Bernard BA ALLAOUCHICHE, PU-PH", 
                    "phone": "0033472116988"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "96433"
                    }, 
                    "name": "University Hospital Edouard Herriot"
                }, 
                "investigator": {
                    "last_name": "Bernard BA ALLAOUCHICHE, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "k-klouche@chu-montpellier.fr", 
                    "last_name": "Kada KK KLOUCHE, dr", 
                    "phone": "0033467338438"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Hospital University of Montpellier"
                }, 
                "investigator": {
                    "last_name": "Kada KK KLOUCHE, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "s-jaber@chu-montpellier.fr", 
                    "last_name": "Samir SJ JABER, Dr", 
                    "phone": "0033467337271"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Hospital University of Montpellier"
                }, 
                "investigator": {
                    "last_name": "Samir SJ JABER, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vincent.das@chi-andregregoire.fr", 
                    "last_name": "Vincent VD DAS, Dr", 
                    "phone": "0033149203073"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreuil", 
                        "country": "France", 
                        "zip": "93105"
                    }, 
                    "name": "Interegional Hospital Andr\u00e9 Gr\u00e9goire"
                }, 
                "investigator": [
                    {
                        "last_name": "Vincent VD DAS, Dr", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Magali MC CIROLDI, Dr", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jean.chastre@psl.aphp.fr", 
                    "last_name": "Jean JC CHASTRE, PU-PH", 
                    "phone": "0033142163821"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "University Hospital of La Piti\u00e9 Salpetri\u00e8re"
                }, 
                "investigator": {
                    "last_name": "Jean JC CHASTRE, Pu-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "michel.wolff@bch.aphp.fr", 
                    "last_name": "Michel MW WOLFF, PU-PH", 
                    "phone": "0033140258123"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75877"
                    }, 
                    "name": "Hospital University of Bichat"
                }, 
                "investigator": {
                    "last_name": "Michel MW WOLFF, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bmisset@hospital-saint-joseph.org", 
                    "last_name": "Bernard BM MISSET, Dr", 
                    "phone": "0033144123415"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75014"
                    }, 
                    "name": "Hospital St Joseph"
                }, 
                "investigator": {
                    "last_name": "Bernard BM MISSET, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "benoir.schlemmer@sls.aphp.fr", 
                    "last_name": "Benoit BS SCHLEMMER, PU-PH", 
                    "phone": "0033142499421"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75010"
                    }, 
                    "name": "University Hospital Saint Louis"
                }, 
                "investigator": [
                    {
                        "last_name": "Benoit BS SCHLEMMER, Pu-PH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Elie EA AZOULAY, Pr", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daniel.combaux@ch-pontoise.fr", 
                    "last_name": "Dani\u00e8le DC COMBAUX, Dr", 
                    "phone": "0033130754104"
                }, 
                "facility": {
                    "address": {
                        "city": "Pontoise", 
                        "country": "France", 
                        "zip": "95303"
                    }, 
                    "name": "Hospital of Pontoise"
                }, 
                "investigator": {
                    "last_name": "Dani\u00e8le dc COMBAUX, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jcousson@chu-reims.fr", 
                    "last_name": "Joel JC COUSSON, Dr", 
                    "phone": "0033326783022"
                }, 
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51092"
                    }, 
                    "name": "Hospital University of Reims"
                }, 
                "investigator": {
                    "last_name": "Joel JC COUSSON, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "reanimation@chd-vendee.fr", 
                    "last_name": "Jean JR REIGNIER, Dr", 
                    "phone": "00 332 51 44 61 61"
                }, 
                "facility": {
                    "address": {
                        "city": "Roche Sur Yon", 
                        "country": "France", 
                        "zip": "85925"
                    }, 
                    "name": "Departemental Hospital of Roche sur Yon"
                }, 
                "investigator": {
                    "last_name": "Jean JR REIGNIER, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "zeni@univ-st-etienne.fr", 
                    "last_name": "Fabrice FZ ZENI, PU-PH", 
                    "phone": "0033477127862"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Etienne", 
                        "country": "France", 
                        "zip": "42055"
                    }, 
                    "name": "University Hospital of Saint Etienne"
                }, 
                "investigator": {
                    "last_name": "Fabrice FZ ZENI, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ferhat.meziani@chru-strasbourg.fr", 
                    "last_name": "Ferhat FM MEZIANI, Dr", 
                    "phone": "0033388116768"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "University Hospital of Strasbourg"
                }, 
                "investigator": [
                    {
                        "last_name": "Ferhat FM MEZIANI, Dr", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "David DS SCHNELL, Dr", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Micafungin Versus Placebo in the Nosocomial Sepsis in Patients Multi-colonized With Candida, Randomized Controlled Trial", 
        "overall_contact": {
            "email": "JFTimsit@chu-grenoble.fr", 
            "last_name": "Jean Francois JFT TIMSIT, PU-PH", 
            "phone": "00 33 4 76 76 87 79"
        }, 
        "overall_contact_backup": {
            "email": "KHammi@chu-grenoble.fr", 
            "last_name": "Khadija KH HAMMI, engineer hospital", 
            "phone": "00 33 4 76 76 71 09"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Grenoble", 
            "last_name": "TIMSIT JFT Jean Fran\u00e7ois, PU-PH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "breakthrough infection defined as a proven infection occurs at least 48 hours after initiation of treatment Proven infection is considered purchased after enrollment if the first significant positive levy occurs after the 48 th hour after enrollment.", 
            "measure": "survival to 28 days without proven fungal infection (a fungal infection occurring within 48 hours after inclusion will be considered available for inclusion)", 
            "safety_issue": "No", 
            "time_frame": "28 days follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01773876"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Reports AUC / MIC and Cmax / MIC will be calculated", 
                "measure": "pharmacokinetic parameters: estimated gross exposure indices: AUC, Cmax, Cmin", 
                "safety_issue": "No", 
                "time_frame": "during  24 hours (between the two first infusions)"
            }, 
            {
                "description": "For all patients who received at least one dose of treatment:\nnumber of adverse events reported after randomization up to 28 days, only death will count up to 3 months post-randomization (information on the long-term survival collected by telephone),\nchanges in the clinical examination, vital signs and laboratory results,\noverall survival defined as the time from randomization to date of death from any cause.\nChanges in liver function tests (bilirubin, ALT, AST, rate prothrombin, alkaline phosphatase) at the end of treatment and at the end study", 
                "measure": "evaluation of tolerance", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "pharmacodynamic parameters: potential serum biomarkers of treatment efficacy (PCR Candida,1,3 \u03b2-D-glucan,mannan antigenemia,anti-mannan,Procalcitonin (proCT))", 
                "safety_issue": "No", 
                "time_frame": "during 28 days"
            }, 
            {
                "measure": "pharmacodynamic parameters: Early prognostic factors of response: J7 survival without proven invasive candidiasis", 
                "safety_issue": "No", 
                "time_frame": "during 14 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible on all-cause mortality at day 28 (end of study) and J90 (3 months post-randomization)", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis can free survival antifungal treatment at day 28", 
                "safety_issue": "No", 
                "time_frame": "during 28 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible evolution of organ failure during the study", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible the use of mechanical ventilation during the study", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible evolution of the colonization index during study", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible changes in serum biomarkers (1-3 \u03b2-D-glucan, mannan antigenemia, anti-mannan Candida PCR) during the study", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }, 
            {
                "measure": "Evaluate the impact of empiric treatment with micafungin in patients with invasive candidiasis possible on the incidence of pneumonia acquired bacterial mechanical ventilation (VAP).", 
                "safety_issue": "No", 
                "time_frame": "during 90 days"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}